XLO

Xilio Therapeutics Inc

2.98
0.07 (2.41%)

Xilio Therapeutics Inc. (XLO) Fundamentals

Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index.
SHARE INFORMATION
Market CapUS$ 79,939,743
Shares Outstanding27,470,702
Float11,120,000
Percent Float40.48%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0.83
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions95
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months103,825
Institutional Holdings Percent60.1%
Institutional Sold Previous 3 Months1,029,743
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months510,500
Insider Holdings Percent1.3
Insider Sold Previous 3 Months-
Insider Shares Owned350,000
TRADING INFO
52 Week HighUS$ 4.92
52 Week LowUS$ 1.95
52 Week High ChangeUS$ 2.46
21 Day Moving AverageUS$ 3.1054
21 Day Extended Moving AverageUS$ 3.0961
50 Day Moving AverageUS$ 3.1325
50 Day Extended Moving AverageUS$ 3.1095
200 Day Moving AverageUS$ 2.8169
200 Day Extended Moving AverageUS$ 3.5656
10 Day Average Volume5,207
20 Day Average Volume11,819
30 Day Average Volume12,404
50 Day Average Volume21,045
Alpha-0.062172
Beta0.3367
Standard Deviation0.203347
R20.008997
7 Day Price ChangeUS$ -0.16
7 Day Percent Change-5.21%
21 Day Price ChangeUS$ -0.29
21 Day Percent Change-9.06%
30 Day Price ChangeUS$ -0.21
30 Day Percent Change-6.73%
Month to Date Price ChangeUS$ -0.14
Month to Date Percent Change-4.59%
Quarter to Date Price ChangeUS$ -0.26
Quarter to Date Percent Change-8.2%
180 Day Price ChangeUS$ 0.52
180 Day Percent Change21.76%
200 Day Price ChangeUS$ 0.4142
200 Day Percent Change16.6%
Year to Date Price ChangeUS$ 0.22
Year to Date Percent Change8.18%

Xilio Therapeutics Inc. (XLO) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.10
Total Debt To Equity0.20
Int Coverage0.00
Current Ratio6.00
Leverage Ratio1.40
Quick Ratio5.80
Long Term Debt To Capital0.11
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 13,594,641
Price to Sales0.00
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book1.10
Price To Cash Flow-0.80
PE Low Last 5 Years0.00
Price to Tangible Book1.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-58.15
Return on Equity-72.80
Return on Capital-62.11

Xilio Therapeutics Inc. (XLO) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEORene Russo
Employees78
Last Audit-
CIK0001840233
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address828 Winter Street,Suite 300
Suite 300
Waltham, MA 2451
Websitehttps://www.xiliotx.com
Facsimile-
Telephone+1 617 430-4680
Email-
Your Recent History
NASDAQ
XLO
Xilio Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230604 00:57:46